BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34843149)

  • 1. High-throughput and multi-phases identification of autoantibodies in diagnosing early-stage breast cancer and subtypes.
    Luo R; Zheng C; Song W; Tan Q; Shi Y; Han X
    Cancer Sci; 2022 Feb; 113(2):770-783. PubMed ID: 34843149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies against TYMS and PDLIM1 proteins detected as circulatory signatures in Indian breast cancer patients.
    Gupta P; Suman S; Mishra M; Mishra S; Srivastava N; Kumar V; Singh PK; Shukla Y
    Proteomics Clin Appl; 2016 May; 10(5):564-73. PubMed ID: 27068564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Autoantibodies Associated with Basal-like Breast Cancers.
    Wang J; Figueroa JD; Wallstrom G; Barker K; Park JG; Demirkan G; Lissowska J; Anderson KS; Qiu J; LaBaer J
    Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1332-40. PubMed ID: 26070530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and validation of an immunodiagnostic model for prediction of breast cancer.
    Qiu C; Wang P; Wang B; Shi J; Wang X; Li T; Qin J; Dai L; Ye H; Zhang J
    Oncoimmunology; 2020; 9(1):1682382. PubMed ID: 32002291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review: Tumor-associated antigen autoantibodies and ovarian cancer early detection.
    Fortner RT; Damms-Machado A; Kaaks R
    Gynecol Oncol; 2017 Nov; 147(2):465-480. PubMed ID: 28800944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of naturally occurring anti-HER2 autoantibodies on breast cancer.
    Tabuchi Y; Shimoda M; Kagara N; Naoi Y; Tanei T; Shimomura A; Shimazu K; Kim SJ; Noguchi S
    Breast Cancer Res Treat; 2016 May; 157(1):55-63. PubMed ID: 27113738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel autoantibody signatures and evaluation of a panel of autoantibodies in breast cancer.
    Qiu C; Wang B; Wang P; Wang X; Ma Y; Dai L; Shi J; Wang K; Sun G; Ye H; Zhang J
    Cancer Sci; 2021 Aug; 112(8):3388-3400. PubMed ID: 34115421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer.
    Liu Y; Liao Y; Xiang L; Jiang K; Li S; Huangfu M; Sun S
    Int J Clin Oncol; 2017 Apr; 22(2):291-296. PubMed ID: 27778118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the diagnostic value of circulating tumor cells with CytoSorter
    Jin L; Zhao W; Zhang J; Chen W; Xie T; Wang L; Fan W; Xie S; Shen J; Zheng H; Hu W; Wei Q; Dong M; Wang Q; Shen J; Liu Y
    Cancer Med; 2020 Mar; 9(5):1638-1647. PubMed ID: 31908156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma.
    Welberry C; Macdonald I; McElveen J; Parsy-Kowalska C; Allen J; Healey G; Irving W; Murray A; Chapman C
    PLoS One; 2020; 15(5):e0232247. PubMed ID: 32374744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibody signature in hepatocellular carcinoma using seromics.
    Zhang S; Liu Y; Chen J; Shu H; Shen S; Li Y; Lu X; Cao X; Dong L; Shi J; Cao Y; Wang X; Zhou J; Liu Y; Chen L; Fan J; Ding G; Gao Q
    J Hematol Oncol; 2020 Jul; 13(1):85. PubMed ID: 32616055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a panel of tumor-associated antigens in breast cancer.
    Pagaza-Straffon C; Marchat LA; Herrera L; Díaz-Chávez J; Avante MG; Rodríguez YP; Arreola MC; López-Camarillo C
    Cancer Biomark; 2020; 27(2):207-211. PubMed ID: 31839604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer.
    Anderson KS; Sibani S; Wallstrom G; Qiu J; Mendoza EA; Raphael J; Hainsworth E; Montor WR; Wong J; Park JG; Lokko N; Logvinenko T; Ramachandran N; Godwin AK; Marks J; Engstrom P; Labaer J
    J Proteome Res; 2011 Jan; 10(1):85-96. PubMed ID: 20977275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies against HSF1 and CCDC155 as Biomarkers of Early-Stage, High-Grade Serous Ovarian Cancer.
    Wilson AL; Moffitt LR; Duffield N; Rainczuk A; Jobling TW; Plebanski M; Stephens AN
    Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):183-192. PubMed ID: 29141850
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of candidate serologic markers for type I and type II ovarian cancer.
    Lu D; Kuhn E; Bristow RE; Giuntoli RL; Kjær SK; Shih IeM; Roden RB
    Gynecol Oncol; 2011 Sep; 122(3):560-6. PubMed ID: 21704359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classifying patients for breast cancer by detection of autoantibodies against a panel of conformation-carrying antigens.
    Evans RL; Pottala JV; Egland KA
    Cancer Prev Res (Phila); 2014 May; 7(5):545-55. PubMed ID: 24641868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation.
    Kaaks R; Fortner RT; Hüsing A; Barrdahl M; Hopper M; Johnson T; Tjønneland A; Hansen L; Overvad K; Fournier A; Boutron-Ruault MC; Kvaskoff M; Dossus L; Johansson M; Boeing H; Trichopoulou A; Benetou V; La Vecchia C; Sieri S; Mattiello A; Palli D; Tumino R; Matullo G; Onland-Moret NC; Gram IT; Weiderpass E; Sánchez MJ; Navarro Sanchez C; Duell EJ; Ardanaz E; Larranaga N; Lundin E; Idahl A; Jirström K; Nodin B; Travis RC; Riboli E; Merritt M; Aune D; Terry K; Cramer DW; Anderson KS
    Int J Cancer; 2018 Aug; 143(3):515-526. PubMed ID: 29473162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.
    Zhou SL; Ku JW; Fan ZM; Yue WB; Du F; Zhou YF; Liu YL; Li Y; Tang S; Hu YL; Hu XP; Hou ZC; Liu J; Liu Y; Feng XS; Wang LD
    Dis Esophagus; 2015; 28(4):371-9. PubMed ID: 24612004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer.
    Schummer M; Thorpe J; Giraldez MD; Bergan L; Tewari M; Urban N
    PLoS One; 2015; 10(11):e0142911. PubMed ID: 26565788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of tumor-associated autoantibodies in the early diagnosis of lung cancer.
    Du Q; Yu R; Wang H; Yan D; Yuan Q; Ma Y; Slamon D; Hou D; Wang H; Wang Q
    Clin Respir J; 2018 Jun; 12(6):2020-2028. PubMed ID: 29356386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.